URMC / Labs / Corsetti Lab / Publications Publications Corsetti JPSalzman PRyan DMoss AJZareba WSparks CE (2016 Sep). Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling. Data in brief. Corsetti JPGansevoort RTBakker SJDullaart RP (2016 Jul). Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study. Journal of clinical lipidology. Corsetti JPSalzman PRyan DMoss AJZareba WSparks CE (2016 Apr 21). Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation. Atherosclerosis. Corsetti JPGansevoort RTBakker SJSparks CEVart PDullaart RP (2014 Dec). Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants. Journal of the American Society of Nephrology : JASN. Sparks CECorsetti JPSparks JD (2014 Jun). High-density lipoproteins: taking the good with the bad. Current opinion in lipidology. Corsetti JPGansevoort RTBakker SJNavis GSparks CEDullaart RP (2012 Jul). Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism: clinical and experimental. Corsetti JPBakker SJSparks CEDullaart RP (2012). Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein. PloS one. Corsetti JPRyan DMoss AJMcCarthy JGoldenberg IZareba WSparks CE (2011 Dec). Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Thrombosis and haemostasis. Refaai MAFialkow LBHeal JMHenrichs KFSpinelli SLPhipps RPMasel ESmith BHCorsetti JPFrancis CWBankey PEBlumberg N (2011 Jul). An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients. Vox sanguinis. Corsetti JPGansevoort RTNavis GSparks CEDullaart RP (2011 Feb). LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. Corsetti JPGansevoort RTSparks CEDullaart RP (2010 Jun). Inflammation reduces HDL protection against primary cardiac risk. European journal of clinical investigation. Casas JPNinio EPanayiotou APalmen JCooper JARicketts SLSofat RNicolaides ANCorsetti JPFowkes FGTzoulaki IKumari MBrunner EJKivimaki MMarmot MGHoffmann MMWinkler KMärz WYe SStirnadel HABoekholdt SMKhaw KTHumphries SESandhu MSHingorani ADTalmud PJ (2010 Jun 1). PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation. Corsetti JPZareba WMoss AJRainwater DLSparks CE (2006 Jul). Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. Atherosclerosis. Corsetti JPRainwater DLMoss AJZareba WSparks CE (2006 Jul). High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients. Clinical chemistry. Corsetti JPZareba WMoss AJSparks CE (2005 Dec). Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients. Atherosclerosis. Corsetti JPZareba WMoss AJSparks CE (2004 Dec). Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome. Atherosclerosis. Corsetti JPZareba WMoss AJRidker PMMarder VJRainwater DLSparks CE (2003 Dec). Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients. Atherosclerosis. Chirieac DVChirieac LRCorsetti JPCianci JSparks CESparks JD (2000 Nov). Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. American journal of physiology. Endocrinology and metabolism. Sparks JDShaw WNCorsetti JPBolognino MPesek JFSparks CE (2000 Nov). Insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity. Metabolism: clinical and experimental. Nieto FJIribarren CGross MDComstock GWCutler RG (2000 Jan). Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. Sparks JDPhung TLBolognino MCianci JKhurana RPeterson RGSowden MPCorsetti JPSparks CE (1998 Nov). Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia. Metabolism: clinical and experimental. Lazova RZSterry JACorsetti JP (1995 Sep). Pseudoparaproteinemia due to hemoglobinopathy. Clinical chemistry. Sparks JDCorsetti JPSparks CE (1994 Jun). Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy. Metabolism: clinical and experimental. Corsetti JPCox CSchulz TJArvan DA (1993 Dec). Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis. Clinical chemistry. Corsetti JPSparks JDSikora BSparks CE (1993 Apr). Cellular heterogeneity in binding and uptake of low-density lipoprotein in primary rat hepatocytes. Hepatology (Baltimore, Md.). Corsetti JPWay BASparks CESparks JD (1992 Jun). Immunolocalization, quantitation and cellular heterogeneity of apolipoprotein B in rat hepatocytes. Hepatology (Baltimore, Md.). Corsetti JPSterry JASparks JDSparks CEWeintraub M (1991 Jul). Effect of weight loss on serum lipoprotein(a) concentrations in an obese population. Clinical chemistry. Corsetti JPWeidner CHCianci JSparks CE (1991 May 15). The labeling of lipoproteins for studies of cellular binding with a fluorescent lipophilic dye. Analytical biochemistry. Corsetti JPSotirchos SVCox CCowles JWLeary JFBlumburg N (1988 Nov). Correction of cellular autofluorescence in flow cytometry by mathematical modeling of cellular fluorescence. Cytometry. Corsetti JPCowles JWCox MTBlumberg N (1988). A rapid and accurate single-drop modification of the acid-elution technique for detecting fetomaternal hemorrhage. Vox sanguinis. Szilagyi PGCorsetti JCallahan CMMcCormick KMetlay LA (1987). Pancreatic exocrine aplasia, clinical features of leprechaunism, and abnormal gonadotropin regulation. Pediatric pathology / affiliated with the International Paediatric Pathology Association. Corsetti JPCox MTCox CBlumberg NLeary JDoherty R (1987 Jan 01). A Comparison of Quantitative Acid Elution Technique and Flow Cytometry for Detecting Low Levels of Fetomaternal Hemorrhage. Annals Clinical Laboratory Science. Corsetti JPKohler BE (1977 Jan 01). Ground and Excited-State Dipole Moments of all-trans retinal and all-trans-retinyledene-n-butylamine in solution. Journal Chemical Physics.